Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007–2014

Ji Yun Noh; Won Suk Choi; Joon Young Song; Han Sol Lee; Sooyeon Lim; Jacob Lee; Yu Bin Seo; Jin Soo Lee; Seong Heon Wie; Hye Won Jeong; Jung Yeon Heo; Young Keun Kim; Kyung Hwa Park; Shin Woo Kim; Sun Hee Lee; Jung Hwa Lee; Dong Hyun Kim; Sung Il Woo; Chae Seung Lim; Kyung Soon Cho; Hee Jin Cheong; Woo Joo Kim

doi:10.1016/j.vaccine.2018.07.021

Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007–2014

Ji Yun Noh, Won Suk Choi, Joon Young Song, Han Sol Lee, Sooyeon Lim, Jacob Lee, Yu Bin Seo, Jin Soo Lee, Seong Heon Wie, Hye Won Jeong, Jung Yeon Heo, Young Keun Kim, Kyung Hwa Park, Shin Woo Kim, Sun Hee Lee, Jung Hwa Lee, Dong Hyun Kim, Sung Il Woo, Chae Seung Lim, Kyung Soon ChoHee Jin Cheong, Woo Joo Kim

Internal Medicine

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

We aimed to characterize the lineages of influenza B viruses obtained from clinical specimens during the 2007–2014 seasons in South Korea. RT-PCR for the partial hemagglutinin gene of influenza B virus was performed on laboratory-confirmed influenza B samples from the 2007–2008 season to 2013–2014 season. A phylogenetic tree was generated, and current influenza vaccine strains for the Northern Hemisphere were used as representative strains of Victoria and Yamagata lineages. A total of 571 influenza B virus sequences were analyzed. During the 2009–2010 season, most of the circulating influenza B viruses matched the vaccine strain; 91.0% (91/100) of viruses belonged to the Victoria lineage. In the 2007–2008, 2011–2012, and 2013–2014 seasons, co-circulation of each influenza B lineage was found with a match ratio to the vaccine strain of 53.2% (42/79), 40.9% (63/154), and 58.3% (134/230), respectively. Overall, 41.7% (238/571) of the circulating influenza B viruses belonged to the lineage mismatching the vaccine strain. During the seven influenza seasons, influenza B epidemics were substantial in four seasons in South Korea. Significant mismatches of the vaccine and lineage of the circulating influenza B viruses were found. The current trivalent influenza vaccine may not be fully suitable for effective protection against influenza B.

Original language	English
Pages (from-to)	5304-5308
Number of pages	5
Journal	Vaccine
Volume	36
Issue number	35
DOIs	https://doi.org/10.1016/j.vaccine.2018.07.021
Publication status	Published - 2018 Aug 23

Bibliographical note

Funding Information:
This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001 ). Funding for this study was also provided by GlaxoSmithKline Biologicals SA [Study 201195]. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript.

Funding Information:
This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001). Funding for this study was also provided by GlaxoSmithKline Biologicals SA [Study 201195]. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript.

Publisher Copyright:
© 2018 Elsevier Ltd

All Science Journal Classification (ASJC) codes

Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2018.07.021

Cite this

Noh, J. Y., Choi, W. S., Song, J. Y., Lee, H. S., Lim, S., Lee, J., Seo, Y. B., Lee, J. S., Wie, S. H., Jeong, H. W., Heo, J. Y., Kim, Y. K., Park, K. H., Kim, S. W., Lee, S. H., Lee, J. H., Kim, D. H., Woo, S. I., Lim, C. S., ... Kim, W. J. (2018). Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007–2014. Vaccine, 36(35), 5304-5308. https://doi.org/10.1016/j.vaccine.2018.07.021

@article{085cb070d38c44cbada98eb980bb58f4,

title = "Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007–2014",

abstract = "We aimed to characterize the lineages of influenza B viruses obtained from clinical specimens during the 2007–2014 seasons in South Korea. RT-PCR for the partial hemagglutinin gene of influenza B virus was performed on laboratory-confirmed influenza B samples from the 2007–2008 season to 2013–2014 season. A phylogenetic tree was generated, and current influenza vaccine strains for the Northern Hemisphere were used as representative strains of Victoria and Yamagata lineages. A total of 571 influenza B virus sequences were analyzed. During the 2009–2010 season, most of the circulating influenza B viruses matched the vaccine strain; 91.0% (91/100) of viruses belonged to the Victoria lineage. In the 2007–2008, 2011–2012, and 2013–2014 seasons, co-circulation of each influenza B lineage was found with a match ratio to the vaccine strain of 53.2% (42/79), 40.9% (63/154), and 58.3% (134/230), respectively. Overall, 41.7% (238/571) of the circulating influenza B viruses belonged to the lineage mismatching the vaccine strain. During the seven influenza seasons, influenza B epidemics were substantial in four seasons in South Korea. Significant mismatches of the vaccine and lineage of the circulating influenza B viruses were found. The current trivalent influenza vaccine may not be fully suitable for effective protection against influenza B.",

author = "Noh, {Ji Yun} and Choi, {Won Suk} and Song, {Joon Young} and Lee, {Han Sol} and Sooyeon Lim and Jacob Lee and Seo, {Yu Bin} and Lee, {Jin Soo} and Wie, {Seong Heon} and Jeong, {Hye Won} and Heo, {Jung Yeon} and Kim, {Young Keun} and Park, {Kyung Hwa} and Kim, {Shin Woo} and Lee, {Sun Hee} and Lee, {Jung Hwa} and Kim, {Dong Hyun} and Woo, {Sung Il} and Lim, {Chae Seung} and Cho, {Kyung Soon} and Cheong, {Hee Jin} and Kim, {Woo Joo}",

note = "Funding Information: This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001 ). Funding for this study was also provided by GlaxoSmithKline Biologicals SA [Study 201195]. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. Funding Information: This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001). Funding for this study was also provided by GlaxoSmithKline Biologicals SA [Study 201195]. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. Publisher Copyright: {\textcopyright} 2018 Elsevier Ltd",

year = "2018",

month = aug,

day = "23",

doi = "10.1016/j.vaccine.2018.07.021",

language = "English",

volume = "36",

pages = "5304--5308",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "35",

}

Noh, JY, Choi, WS, Song, JY, Lee, HS, Lim, S, Lee, J, Seo, YB, Lee, JS, Wie, SH, Jeong, HW, Heo, JY, Kim, YK, Park, KH, Kim, SW, Lee, SH, Lee, JH, Kim, DH, Woo, SI, Lim, CS, Cho, KS, Cheong, HJ & Kim, WJ 2018, 'Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007–2014', Vaccine, vol. 36, no. 35, pp. 5304-5308. https://doi.org/10.1016/j.vaccine.2018.07.021

TY - JOUR

T1 - Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007–2014

AU - Noh, Ji Yun

AU - Choi, Won Suk

AU - Song, Joon Young

AU - Lee, Han Sol

AU - Lim, Sooyeon

AU - Lee, Jacob

AU - Seo, Yu Bin

AU - Lee, Jin Soo

AU - Wie, Seong Heon

AU - Jeong, Hye Won

AU - Heo, Jung Yeon

AU - Kim, Young Keun

AU - Park, Kyung Hwa

AU - Kim, Shin Woo

AU - Lee, Sun Hee

AU - Lee, Jung Hwa

AU - Kim, Dong Hyun

AU - Woo, Sung Il

AU - Lim, Chae Seung

AU - Cho, Kyung Soon

AU - Cheong, Hee Jin

AU - Kim, Woo Joo

N1 - Funding Information: This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001 ). Funding for this study was also provided by GlaxoSmithKline Biologicals SA [Study 201195]. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. Funding Information: This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001). Funding for this study was also provided by GlaxoSmithKline Biologicals SA [Study 201195]. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript. Publisher Copyright: © 2018 Elsevier Ltd

PY - 2018/8/23

Y1 - 2018/8/23

N2 - We aimed to characterize the lineages of influenza B viruses obtained from clinical specimens during the 2007–2014 seasons in South Korea. RT-PCR for the partial hemagglutinin gene of influenza B virus was performed on laboratory-confirmed influenza B samples from the 2007–2008 season to 2013–2014 season. A phylogenetic tree was generated, and current influenza vaccine strains for the Northern Hemisphere were used as representative strains of Victoria and Yamagata lineages. A total of 571 influenza B virus sequences were analyzed. During the 2009–2010 season, most of the circulating influenza B viruses matched the vaccine strain; 91.0% (91/100) of viruses belonged to the Victoria lineage. In the 2007–2008, 2011–2012, and 2013–2014 seasons, co-circulation of each influenza B lineage was found with a match ratio to the vaccine strain of 53.2% (42/79), 40.9% (63/154), and 58.3% (134/230), respectively. Overall, 41.7% (238/571) of the circulating influenza B viruses belonged to the lineage mismatching the vaccine strain. During the seven influenza seasons, influenza B epidemics were substantial in four seasons in South Korea. Significant mismatches of the vaccine and lineage of the circulating influenza B viruses were found. The current trivalent influenza vaccine may not be fully suitable for effective protection against influenza B.

AB - We aimed to characterize the lineages of influenza B viruses obtained from clinical specimens during the 2007–2014 seasons in South Korea. RT-PCR for the partial hemagglutinin gene of influenza B virus was performed on laboratory-confirmed influenza B samples from the 2007–2008 season to 2013–2014 season. A phylogenetic tree was generated, and current influenza vaccine strains for the Northern Hemisphere were used as representative strains of Victoria and Yamagata lineages. A total of 571 influenza B virus sequences were analyzed. During the 2009–2010 season, most of the circulating influenza B viruses matched the vaccine strain; 91.0% (91/100) of viruses belonged to the Victoria lineage. In the 2007–2008, 2011–2012, and 2013–2014 seasons, co-circulation of each influenza B lineage was found with a match ratio to the vaccine strain of 53.2% (42/79), 40.9% (63/154), and 58.3% (134/230), respectively. Overall, 41.7% (238/571) of the circulating influenza B viruses belonged to the lineage mismatching the vaccine strain. During the seven influenza seasons, influenza B epidemics were substantial in four seasons in South Korea. Significant mismatches of the vaccine and lineage of the circulating influenza B viruses were found. The current trivalent influenza vaccine may not be fully suitable for effective protection against influenza B.

UR - http://www.scopus.com/inward/record.url?scp=85050402037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050402037&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2018.07.021

DO - 10.1016/j.vaccine.2018.07.021

M3 - Article

C2 - 30057284

AN - SCOPUS:85050402037

SN - 0264-410X

VL - 36

SP - 5304

EP - 5308

JO - Vaccine

JF - Vaccine

IS - 35

ER -

Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007–2014

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this